In addition, liraglutide was expanded to adolescent obese patients aged 12 years and older in 2020
Strategies for Off-Patent Players Pricing pressures With multiple generic manufacturers expected to enter the market at launch, aggressive price competition is likely, particularly in countries where GLP-1 pricing remains high by international standards
When treatments were initiated, mice had ad libitum access to food, water, and kaolin pellets
Customised testing methods are used to cover all aspects of a nasal device from broad parameters (dosage accuracy, leakage, weight loss, etc) to in-depth spray characterisation
However, the biosimilar pathway for complex peptide medications is accelerating, and several manufacturers have signaled interest in developing competing versions once patents expire